Storgate’s Cytokinetics CYTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$699K Buy
+10,610
New +$809K 0.12% 126

Other funds holding CYTK

Storgate's CYTK Position: Q3 2026 in Review

Storgate opened a new position in Cytokinetics (CYTK) in Q3 2026: 10,610 shares worth $699K. The stake represents 0.12% of the portfolio and ranks #126 among its holdings.

465 funds tracked by Wall St. Rank hold CYTK as of Q3 2026.

  • Storgate held 10,610 shares of Cytokinetics worth $699K as of Q3 2026.
  • Cytokinetics was a new Storgate position in Q3 2026.
  • Cytokinetics made up 0.12% of Storgate's portfolio in Q3 2026, its #126 holding.
  • 465 funds tracked by Wall St. Rank held Cytokinetics as of Q3 2026.

Based on Storgate's 13F filing for Q3 2026, filed 12 Nov 2026.